Sanofi (SNYNF) stock
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Sanofi EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was 6.37 EUR, up 43.8% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is 9.77 EUR in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6.37 EUR | +43.8% |
| FY2024 | Dec 31, 2024 | 4.43 EUR | +3.0% |
| FY2023 | Dec 31, 2023 | 4.30 EUR | -35.4% |
| FY2022 | Dec 31, 2022 | 6.66 EUR | +34.5% |
| FY2021 | Dec 31, 2021 | 4.95 EUR | -49.3% |
| FY2020 | Dec 31, 2020 | 9.77 EUR | +338.1% |
| FY2019 | Dec 31, 2019 | 2.23 EUR | -35.0% |
| FY2018 | Dec 31, 2018 | 3.43 EUR | -48.3% |
| FY2017 | Dec 31, 2017 | 6.64 EUR | +82.9% |
| FY2016 | Dec 31, 2016 | 3.63 EUR | +11.7% |
| FY2015 | Dec 31, 2015 | 3.25 EUR | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?